Haemoband Surgical

What Haemoband Surgical does

Haemoband Surgical Ltd. is a privately held, founder-owned medical device company headquartered in Belfast, Northern Ireland, founded in 2005 by Consultant Surgeon Dr. Essam Ghareeb. The company designs, develops, and manufactures single-use disposable devices for the outpatient treatment of haemorrhoids, with approximately two million devices sold across 40+ countries. Its portfolio consists of two core products: the Haemoband-PLUS Band Ligator — a pre-loaded, four-band suction-assisted rubber band ligator with a dual-action trigger and transparent nozzle that enables single-operator procedures in 2–3 minutes without anaesthetic — and the HB-SleeveLUX Proctoscope, a self-illuminating disposable proctoscope with patented Comfort Sleeve and Locking Technology launched in 2022. Four international patents protect the technology, and the company holds FDA 510(k), CE Mark (with EU MDR 2017/745 transition completed), and ISO 13485:2016 certifications.

Haemoband generates revenue exclusively through hardware sales of these disposable devices, with pricing handled via quote-based distributor agreements and no public list pricing. The company operates a 100% channel-based go-to-market model, appointing exclusive territorial distributors in each country and recruiting new partners at major medical conferences (ASCRS, MEDICA, FIME, Arab Health). Named channel partners include MDA in Hong Kong/Macau (since 2007), Hallmark Surgical in New Zealand (since 2015; ~45–50% market share), Kebomed Benelux in the Netherlands/Belgium/Luxembourg, and Exodus Scientific in the USA (appointed 2022). End customers are colorectal surgeons, gastroenterologists, and hospital outpatient departments performing rubber band ligation procedures.

The business is run by a small leadership team of fewer than ten people: Dr. Essam Ghareeb (Chairman, Founder and Clinical Director), Michael McMullan (Managing Director, appointed October 2021 to lead international expansion), Cathal Donnelly (Operations Executive), and Fouad Ghareeb (R&D Engineer). Clinical differentiation rests on published evidence covering 3,000+ patients across four studies, including a 90% single-session success rate, 84.5% asymptomatic rate at 2-year follow-up, and statistically significant reductions in pain, analgesic use, and intra-procedure bleeding versus forceps-based ligation.

Name

Haemoband Surgical

Legal name

Haemoband Surgical Ltd.

Website

https://haemobandsurgical.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Haemoband Surgical Ltd. is a Belfast-based, privately held medical device company that designs and manufactures single-use disposable haemorrhoid ligation devices (Haemoband-PLUS) and proctoscopes (HB-SleeveLUX), selling exclusively through exclusive territorial distributors to colorectal surgeons, gastroenterologists, and hospital outpatient departments across 40+ countries.

Ownership category

akta.pro rank

Product category

Colorectal Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industries

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

Keywords

• Rubber band ligators
• Colorectal medical devices
• Disposable proctoscopes
• Haemorrhoid treatment devices
• Suction ligation devices

Headquarters

HQ city

Belfast

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Medical Device Sales: Haemoband Surgical generates revenue through the sale of its proprietary medical devices - primarily the Haemoband-PLUS multi-band ligators and HB-SleeveLUX proctoscopes. Products are single-use disposable devices sold through a global distributor network to hospitals, clinics, and specialist colorectal/GI practices.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Haemoband Surgical manufactures and sells single-use, disposable medical devices for the outpatient treatment of symptomatic internal haemorrhoids. Its core product, the Haemoband-PLUS Multi-Band Ligator, is a pre-loaded suction-assisted rubber band ligator with four individually moulded latex-free bands enabling treatment in 2-3 minutes without anaesthetic. Its companion product, the HB-SleeveLUX Proctoscope, is a self-illuminating disposable proctoscope with patented Comfort Sleeve and locking technology for use in diagnosis and treatment of anal canal and lower rectum conditions. Both products are designed, developed, and manufactured in Belfast, Northern Ireland.

Product overview

Haemoband Surgical is a Northern Ireland-based medical device manufacturer offering a focused portfolio of two core products for colorectal surgery. The Haemoband-PLUS Band Ligator is the primary offering—a suction-assisted multi-band ligator for rubber band ligation of haemorrhoids, featuring four pre-loaded bands and single-operator operation. The HB-SleeveLUX Proctoscope is a companion device—a self-illuminating, fully disposable proctoscope designed to work alongside the ligator for procedures. Both products are designed, developed, and manufactured in Northern Ireland. The company holds four international patents and has sold approximately two million devices globally across 40+ countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Haemoband-PLUS Multi-Band Ligator A single-use, pre-loaded suction rubber band ligator for treating symptomatic first, second, and third degree haemorrhoids. Features four individually moulded latex-free bands, a dual-action trigger for single-operator use, and a transparent nozzle tip for direct visualisation before firing. The procedure takes 2-3 minutes without anaesthetic and is designed for colorectal surgeons, gastroenterologists, and proctologists performing outpatient banding.
• HB-SleeveLUX Proctoscope A single-use, self-illuminating, fully disposable proctoscope with integrated battery-powered LED light for diagnosis and treatment of conditions of the anal canal and lower rectum. Features patented Comfort Sleeve technology that shields sensitive tissue below the dentate line and a locking mechanism preventing accidental removal, enabling 360-degree rotation without patient discomfort. Available in two diameter sizes and designed to be used alongside the Haemoband-PLUS ligator by colorectal surgeons and gastroenterologists.

Quantifiable outcome

• 90% of patients successfully treated in a single session
• +7 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Reforest NationcoreStrategic or Co-development Partner · 9 December 2024Haemoband Surgical partnered with Reforest Nation, Ireland's foremost tree-planting organisation, to offset carbon footprint and support reforestation efforts. Partnership includes planting trees in the Freedom Forest using the Miyawaki method in Greystones, Co. Wicklow. The forest grows 10x faster, absorbs 10x more carbon, and supports 100x more biodiversity than conventional forests. Company is also an official supporter of the Responsible Plastic Management (RPM) Programme.
• MDA (Medical Distribution Agency)coreChannel Partner/ Reseller/ DistributorExclusive distributor for Haemoband in Hong Kong and Macau since 2007. MDA is a 9-person company established in 2004 specializing in surgical devices. Haemoband is used in major hospitals including St. Teresa's Hospital, Tuen Mun Hospital, and North District Hospital (each consuming 500+ units annually).
• Hallmark SurgicalcoreChannel Partner/ Reseller/ DistributorDistributor of Distinction for Haemoband in New Zealand since 2015. 8-person team with strong category leadership focus. Haemoband-PLUS used in 12 of 19 public hospitals and 36 of 51 private hospitals/colorectal clinics. Current market penetration estimated at 45-50% with target of 60-70% within 2 years.
• Kebomed BeneluxcoreChannel Partner/ Reseller/ DistributorExclusive distributor for Haemoband in Netherlands, Belgium, and Luxembourg. Leon Harst has led Haemoband's market development in Benelux for over 10 years. Kebomed Benelux covers operating theatre materials, x-ray protection, gynaecology, cardiology, urology, and surgical equipment.
• Exodus ScientificcoreChannel Partner/ Reseller/ DistributorAppointed as Haemoband distributor in the USA in 2022. Significant regulatory investment required to meet FDA requirements. Marked as an important milestone in global expansion.
• ABHI (Association of British HealthTech Industries)minorGTM or Marketing PartnerHaemoband Surgical exhibited at MEDICA 2022 and 2023 as part of the ABHI UK Pavilion. ABHI is the UK's leading industry association for health technology with 300 members representing approximately 80% of the sector by value.
• Hallmark SurgicalcoreChannel Partner/ Reseller/ DistributorTestimonial from Hallmark Surgical noting 'surgeons around the world love to Haemoband' with just under two million devices sold globally. Distributor has conducted competitive analysis showing Haemoband as market leader across 13 key attributes including setup time, procedure length, suction control, and band quality.

Scale indicators8 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Olympus Corporation: Olympus is the dominant endoscopy and proctoscope manufacturer globally, offering reusable and single-use proctoscopes that directly overlap with the HB-SleeveLUX product line in the same colorectal diagnostic and treatment workflow.
• Cook Medical: Cook Medical is a large diversified medical device manufacturer offering a broad range of surgical and GI instruments including products used in proctology; competes broadly with Haemoband for colorectal/GI hospital purchasing decisions.
• Karl Storz: Karl Storz is a leading endoscopy and visualization manufacturer with reusable proctoscopes and rigid endoscopes; competes with the HB-SleeveLUX in the diagnostic/visualization portion of the haemorrhoid banding procedure.
• Boston Scientific: Boston Scientific is a broad-based medical device incumbent offering endoscopy and surgical solutions that overlap with the colorectal procedural space in which Haemoband operates, competing for hospital contracts at the category level.
• Medtronic: Medtronic is a global medtech incumbent with a large surgical and GI portfolio that includes endoscopic and colorectal surgical instruments; while not a dedicated haemorrhoid ligation specialist, it competes for the same hospital procurement budgets and surgeon mindshare.

Direct peers

• THD SpA: THD is an Italian medical device company specializing in haemorrhoid and colorectal treatments, offering Doppler-guided hemorrhoidal dearterialization (THD Doppler) and minimally invasive alternatives; competes with Haemoband for the same colorectal surgeon customer and patient pool.
• AMI (Agency for Medical Innovations): Austrian medical device manufacturer focused on proctology and colorectal surgical instruments, including haemorrhoid and fistula treatment devices, overlapping directly with Haemoband's proctoscope and colorectal instrument offerings.
• CRH Medical (CRH O'Regan System): CRH O'Regan System is the most well-known competing single-use haemorrhoid band ligation device globally, directly competing with Haemoband-PLUS in the same colorectal/GI outpatient procedure, with a similar suction/ligation mechanism and a comparable distributor-based commercial model.

Emerging players

• Sklar Instruments: Sklar Instruments manufactures reusable and disposable surgical instruments including rectal and proctology instruments, serving hospitals and clinics with lower-cost alternatives; competes for the same outpatient proctology instrument purchasing decisions as Haemoband.
• Biolitec (ELVeS Laser / LHP): Biolitec offers laser haemorrhoidoplasty (LHP) and other laser-based proctology procedures as alternative minimally invasive treatments to rubber band ligation, representing a partial-substitute technology that competes for the same patient pool Haemoband serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/Haemoband
• YouTubeyoutube.com/channel/UCmvucCqgr7r3RShHw59ugpg
• Facebookfacebook.com/profile.php?id=61579049420694
• LinkedInlinkedin.com/company/haemoband-surgical-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haemoband Surgical